DYNE THERAPEUTICS INC shareholders Q1 2021

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 76 filers reported holding DYNE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

DYNE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$76,894,00014.86%
Vida Ventures Advisors, LLC 2,960,046$45,970,00011.61%
Logos Global Management LP 3,204,392$49,764,0004.86%
Octagon Capital Advisors LP 583,649$9,064,0003.41%
COMMODORE CAPITAL LP 430,112$6,680,0002.66%
Altium Capital Management LP 166,636$2,588,0000.72%
RA Capital Management 2,805,045$43,562,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 450,064$6,989,0000.54%
Soleus Capital Management, L.P. 174,360$2,708,0000.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 93,886$1,453,0000.38%
Vivo Capital, LLC 577,642$8,971,0000.32%
Casdin Capital, LLC 610,000$9,473,0000.28%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 686,000$10,654,0000.22%
HHLR ADVISORS, LTD. 1,000,000$15,530,0000.15%
EcoR1 Capital, LLC 215,000$3,339,0000.15%
Artal Group S.A. 525,000$8,153,0000.14%
Woodline Partners LP 382,493$5,940,0000.13%
HARVARD MANAGEMENT CO INC 107,252$1,666,0000.09%
Maven Securities LTD 91,562$1,394,0000.06%
Redmond Asset Management, LLC 12,513$194,0000.06%
External links

This page lists DYNE THERAPEUTICS INC's shareholders in Q1 2021. To view DYNE THERAPEUTICS INC's shareholder history, click here.